Jul 30, 2020 | All News, INCA
The first Global Survey of NET patients, a collaboration between INCA and Novartis, continues to have an impact worldwide with results published in medical journals. We are excited to announce that the manuscript, “French Patient-Reported Experience of Diagnosis,...
Jul 28, 2020 | All News, INCA
The SCAN project, managed by the INCA Access Committee, collected vast and robust global data on the many challenges in access to diagnostics and treatment of neuroendocrine cancer patients. SCAN became the biggest global compendium of data about NETs to date, with...
Jul 27, 2020 | All News, INCA
INCA is delighted to share that the abstract Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – Healthcare Quality Evaluation was accepted for e-poster presentation (display) at the ESMO Virtual Congress 2020,...
Jul 26, 2020 | All News, INCA, Research and Clinical Trials
The INCA Boot Camp for Research Advocates, managed by the INCA Research Committee, dedicated its first training session on July 15th to several topics of crucial importance. A detailed presentation on how and why patients need to be involved in medicine development...
Jun 30, 2020 | All News, INCA
INCA is proud to share that the abstract Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – Usage & Affordability of Nuclear Medicine Tools, a Comparative Perspective has been accepted as an oral...
Jun 29, 2020 | All News, INCA, Uncategorized
INCA will have a poster presentation at the ESMO World Congress on Gastrointestinal Cancer, which will be held online from July 1st – July 4th . The poster, based on SCAN survey data clearly demonstrates the many challenges with misdiagnosis, non-availability of...
